16 April 2026

---

Henry Schein Announces Board Reduction Plan

---

Henry Schein, Inc. (Nasdaq: HSIC), the world’s largest provider of healthcare solutions to office-based dental and medical practitioners, today announced its plan to reduce the size of its Board of Directors following its 2026 Annual Meeting of Stockholders on May 21, 2026.

Stanley M. Bergman is to retire from the Board after 44 years as a director of Henry Schein. In recognition of Mr. Bergman’s leadership and the significant contributions he has made to the Company, the Board will designate Mr. Bergman Chairman Emeritus, effective immediately following the 2026 Annual Meeting.

“As I transition to the role of Chairman Emeritus, I do so with deep confidence in our leadership and the future of this organization. Fred Lowery is the right person to lead Henry Schein into the next chapter, bringing vision, strong values, and a commitment to excellence,” said Mr. Bergman. “It has been an honor to serve as CEO and Chairman, and I look forward to remaining actively engaged in supporting the Board and management team in this new capacity.”

“On behalf of the entire organization, we would like to extend our gratitude to Stanley for his extraordinary leadership over many years, and we look forward to continuing to benefit from his insights and deep knowledge of Henry Schein and our industry in his role as Chairman Emeritus,” said Philip Laskawy, Lead Director of Henry Schein’s Board of Directors.

In addition, Joseph L. Herring, Robert J. Hombach, Scott Serota, and Bradley T. Sheares will not stand for reelection at the Annual Meeting of Stockholders. Accordingly, the Board of Directors has approved a reduction in size from fifteen to ten members, effective as of the end of the Annual Meeting. “We would like to thank each of these retiring directors for their contributions and service. Their expertise and guidance have been instrumental to Henry Schein throughout their tenures,” added Mr. Laskawy.

The incumbent directors nominated for election at the 2026 Annual Meeting are: Mohamad Ali, William K. “Dan” Daniel, Deborah Derby, Carole T. Faig, Kurt P. Kuehn, Philip A. Laskawy, Max Lin, Frederick M. Lowery, Anne H. Margulies, and Reed V. Tuckson. The Board believes this slate of directors will continue to enable robust dialogue and debate in the boardroom while maintaining the right mix of perspectives, experience, and skills.

About Henry Schein, Inc.

Henry Schein, Inc. (Nasdaq: HSIC) is a solutions company for health care professionals powered by a network of people and technology. With approximately 25,000 Team Schein Members worldwide, the Company’s network of trusted advisors provides more than 1 million customers globally with more than 300 valued solutions that help improve operational success and clinical outcomes. Our business, clinical, technology, and supply chain solutions help office-based dental and medical practitioners work more efficiently so they can provide quality care more effectively. These solutions also support dental laboratories, government and institutional health care clinics, as well as other alternate care sites.

Henry Schein operates through a centralized and automated distribution network, with a selection of more than 300,000 branded products and Henry Schein corporate brand products in its main distribution centers.

A FORTUNE 500 Company and a member of the S&P 500® index, Henry Schein is headquartered in Melville, N.Y., and has operations or affiliates in 34 countries and territories. The Company’s sales reached $13.2 billion in 2025 and have grown at a compound annual rate of approximately 11.0 percent since Henry Schein became a public company in 1995.

Source: www.henryschein.com